Endo International plc, a specialty pharmaceutical company, manufactures and sells generic and branded pharmaceuticals in the United States and internationally. Its Branded Pharmaceuticals segment provides branded prescription products, including XIAFLEX to treat adult patients with Dupuytren's contracture; SUPPRELIN LA to treat central precocious puberty in children; NASCOBAL nasal spray to treat vitamin B12 deficiency; AVEED to treat hypogonadism; QWO, an injectable treatment for moderate to severe cellulite in the buttocks of adult women; PERCOCET to treat moderate-to-moderately-severe pain; TESTOPEL an implantable pellet indicated for TRT in conditions associated with a deficiency or absence of endogenous testosterone; EDEX to treat erectile dysfunction; LIDODERM a topical patch product containing lidocaine for the relief of pain; and products for the pain management and urology. The company's Sterile Injectables segment manufactures VASOSTRICT, a vasopressin injection; ADRENALIN, a non-selective adrenergic agonist; and APLISOL, which is a sterile aqueous solution, as well as generic sterile injectable products, including ertapenem for injections and ephedrine sulfate injections. Its Generic Pharmaceuticals segment offers solid oral extended-release, solid oral immediate-release, liquids, semi-solids, patches, powders, ophthalmic products, and sprays. The company's International Pharmaceuticals segment offers specialty pharmaceutical products in various therapeutic areas comprising attention deficit hyperactivity disorder, pain, women's health, oncology, and transplantation. The company sells its branded pharmaceuticals and generics to specialty physicians, retailers, clinics, government agencies, doctors, retail and specialty pharmacies, and specialty distributors. Endo International plc was founded in 1920 and is headquartered in Dublin, Ireland. On August 16, 2022, Endo International plc, along with its affiliates, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the Southern District of New York.
Show more...
CEO
Blaise Coleman
Pekerja
2931
Negara
IE
ISIN
IE00BJ3V9050
WKN
000A1XE6M
Penyenaraian
0 Comments
Kongsi pendapat anda
FAQ
Berapakah harga saham Endo International hari ini?▼
Harga semasa ENDPQ ialah $0 USD — telah meningkat sebanyak +0% dalam 24 jam yang lalu. Pantau prestasi harga saham Endo International dengan lebih dekat pada carta.
Apakah simbol saham Endo International?▼
Bergantung pada bursa, simbol saham mungkin berbeza. Sebagai contoh, di bursa , saham Endo International didagangkan di bawah simbol ENDPQ.
Berapakah hasil Endo International untuk tahun lepas?▼
Hasil Endo International untuk tahun lalu berjumlah 2.01B USD.
Berapakah pendapatan bersih Endo International untuk tahun lepas?▼
Pendapatan bersih ENDPQ untuk tahun lepas ialah -2.45B USD.
Berapa ramai pekerja yang dimiliki oleh Endo International?▼
Sehingga April 03, 2026, syarikat mempunyai 2,931 pekerja.
Endo International terletak dalam sektor apa?▼
Endo International beroperasi dalam sektor Professional, Scientific, and Technical Services.
Bilakah Endo International menyiapkan split saham?▼
Endo International tidak mempunyai sebarang split baru-baru ini.
Di manakah ibu pejabat Endo International?▼
Ibu pejabat Endo International terletak di Dublin, IE.